Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

New treatments for male hypogonadism are effective and should be personalized.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The document explains various skin conditions and their treatments.

Balding men, especially young ones, may have higher risk of heart issues and diabetes; check cholesterol levels.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Smoking linked to hair loss in Asian men.

New genetic mutations linked to rare skin disorders were found in three newborns.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Heavy metals in personal care products can cause serious health issues like cancer and hair loss.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Vitamin D is crucial for skin health and managing skin diseases.

PRP injections and scalp lifting together improve hair thickness and growth in hair loss patients.

The Rotterdam Study aims to understand various diseases in older adults.

Biologics for severe asthma have known side effects, but some new risks need more study.

HIV-positive pregnant women are more likely to experience severe bleeding, and a pregnant woman with familial hypertriglyceridemia had a successful early delivery with special care.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.